Now showing items 1-2 of 2
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
(Journal of Personalized Medicine, 2018)
Abstract: Insurance coverage policies are a major determinant of patient access to genomic tests. The objective of this study was to examine differences in coverage policies for guideline-recommended pharmacogenomic tests ...
Approaches to Carrier Testing and Results Disclosure in Translational Genomics Research
(Molecular Genetics & Genomic Medicine, 2017)
Background: Clinical genome and exome sequencing (CGES) is primarily used to address specific clinical concerns by detecting risk of future disease, clarifying diagnosis, or directing treatment. Additionally, CGES makes ...